
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading applied research organization in Germany is seeking a Director for its Institute for Toxicology and Experimental Medicine. The role requires a visionary leader with extensive experience in strategic planning, multidisciplinary research, and strong industry connections. This impactful position offers a chance to advance translational research and strengthen collaborations in health and pharmaceutical sciences. Candidates should demonstrate a commitment to equality and diversity in research cultures. Applications are welcome from qualified individuals, including those with disabilities.
The Fraunhofer-Gesellschaft and Hannover Medical School (MHH) are seeking to appoint a suitable candidate at the earliest possible opportunity to fill the joint position (“Jülich model”) of the Director of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, with a University Professor (W3) in Toxicology and Experimental Medicine in a non-pay-scale employment relationship or civil servant relationship according to pay grade W3 of the Niedersachsen pay scale (Besoldungsordnung Niedersachsen, NBesO).
Applications are invited to fill this important and influential position as the Director of ITEM with a Professorship in Toxicology and Experimental Medicine in Hannover Medical School. This position offers a unique opportunity to shape and lead a high-impact translational research agenda at the interface of academia and applied science. It brings together world-class research infrastructure, interdisciplinary collaboration, and direct influence on the future of drug discovery, development and safety with clinical innovation.
Fraunhofer ITEM specializes in drug development, respiratory medicine, and chemical safety, with focus on lung research. The institute currently employs around 330 staff. Its directorate plays a central role in driving the strategic evolution of the institute in line with Fraunhofer’s overarching innovation model. As part of the Fraunhofer-Gesellschaft, the world’s leading applied research organization, Fraunhofer ITEM bridges the gap between science and industry. It focuses on future-defining technologies, translation of basic scientific discovery to the patient, and practical implementation for public and economic benefit.
In the role as Director of the Fraunhofer ITEM the suitable candidate will be responsible for the scientific, technical and entrepreneurial strategy and management of Fraunhofer ITEM.
Hannover Medical School (MHH) and Fraunhofer ITEM maintain a deep, long-standing partnership, particularly in respiratory medicine, toxicology, pharmacology and clinical pharmacology. The candidate’s role will also include further strengthening of this collaboration.
The professorship is expected to represent the field of toxicology and experimental medicine in both research and teaching. The successful candidate will be a visionary, collaborative researcher with a strong international reputation in preclinical and clinical therapeutic development and/or the toxicological assessment of chemicals.
Applicants should meet the appointment requirements in accordance with § 25 of the Lower Saxony Higher Education Act.
Both MHH and Fraunhofer are strongly committed to fostering an inclusive research culture. Qualified individuals with any disabilities will be given preferential consideration. Both institutions promote diversity and actively encourage applications from women in science and leadership.
The complete application documents must be submitted in PDF format by 2nd February 2026 to the president of the Fraunhofer-Gesellschaft (Praesident@fraunhofer.de) and the president of MHH (berufungsverfahren@mh-hannover.de). For further information, please contact Dr. Birgit Geier (Birgit.Geier@zv.fraunhofer.de) at Fraunhofer or Dr. Sebastian Riese (Riese.Sebastian@mh-hannover.de) at MHH.